Pituitary somatostatin receptor signaling

被引:150
|
作者
Ben-Shlomo, Anat [1 ]
Melmed, Shlomo [1 ]
机构
[1] Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA
来源
关键词
GROWTH-HORMONE-SECRETION; RAT ANTERIOR-PITUITARY; INTRACELLULAR FREE CALCIUM; MESSENGER-RNA EXPRESSION; ADENOMAS IN-VITRO; GENE-EXPRESSION; TUMOR-CELLS; QUANTITATIVE-ANALYSIS; PROLACTIN SECRETION; CUSHINGS-DISEASE;
D O I
10.1016/j.tem.2009.12.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Somatotropin-release inhibitory factor (SRIF) is a major regulator of pituitary function, mostly inhibiting hormone secretion and to a lesser extent pituitary cell growth. Five SRIF receptor subtypes (SSTR1-5) are ubiquitously expressed G-protein coupled receptors. In the pituitary, SSTR1, 2, 3 and 5 are expressed, with SSTR2 and SSTR5 predominating. As new SRIF analogs have recently been introduced for treatment of pituitary disease, we evaluate the current knowledge of cell-specific pituitary SRIF receptor signaling and highlight areas of future research for comprehensive understanding of these mechanisms. Elucidating pituitary SRIF receptor signaling enables understanding of pituitary hormone secretion and cell growth, and also encourages future therapeutic development for pituitary disorders.
引用
收藏
页码:123 / 133
页数:11
相关论文
共 50 条
  • [31] Somatostatin receptor subtypes: Specific expression and signaling properties
    Schonbrunn, A
    Gu, YZ
    Dournard, P
    Beaudet, A
    Tannenbaum, GS
    Brown, PJ
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (08): : 8 - 11
  • [32] Receptor signaling and endocytosis are differentially regulated by somatostatin analogs
    Liu, QS
    Cescato, R
    Dewi, DA
    Rivier, J
    Reubi, JC
    Schonbrunn, A
    MOLECULAR PHARMACOLOGY, 2005, 68 (01) : 90 - 101
  • [33] Somatostatin receptor scintigraphy in pituitary adenomas: A somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivo
    Duet, M
    Ajzenberg, C
    Benelhadj, S
    Lajeunie, E
    Lormeau, B
    Guillausseau, PJ
    Rohmer, V
    Vilain, D
    Mundler, O
    Warnet, A
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (08) : 1252 - 1256
  • [34] Expression of somatostatin receptor subtypes in primary and recurrent gonadotropinomas: are somatostatin receptors involved in pituitary adenoma recurrence?
    Pisarek, Hanna
    Kunert-Radek, Jolanta
    Radek, Maciej
    Swietoslawski, Jacek
    Winczyk, Katarzyna
    Pawlikowski, Marek
    NEUROENDOCRINOLOGY LETTERS, 2011, 32 (01) : 96 - 101
  • [35] Somatostatin receptors in pituitary somatotroph adenomas as predictors of response to somatostatin receptor ligands: A pathologist's perspective
    Botelho, Laura
    Dezonne, Romulo Sperduto
    Wildemberg, Luiz Eduardo
    Miranda, Renan Lyra
    Gadelha, Monica R.
    Andreiuolo, Felipe
    BRAIN PATHOLOGY, 2025, 35 (01)
  • [36] SOMATOSTATIN RECEPTOR SUBTYPE GENE-EXPRESSION IN PITUITARY-ADENOMAS
    MILLER, GM
    ALEXANDER, JM
    BIKKAL, HA
    KATZNELSON, L
    ZERVAS, NT
    KLIBANSKI, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (04): : 1386 - 1392
  • [37] Both overlapping and distinct signaling pathways for somatostatin receptor subtypes SSTR1 and SSTR2 in pituitary cells
    Chen, LC
    Fitzpatrick, VD
    Vandlen, RL
    Tashjian, AH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18666 - 18672
  • [38] Thyroid hormones regulate the expression of somatostatin receptor subtypes in the rat pituitary
    Lam, KSL
    Wong, RLC
    NEUROENDOCRINOLOGY, 1999, 69 (06) : 460 - 464
  • [40] Somatostatin and dopamine receptor expression in pituitary adenomas: implications for clinical management
    Wildenberg, L. E.
    BRAIN PATHOLOGY, 2014, 24 : 25 - 25